Picard Medical (PMI) Return on Sales (2024 - 2026)

Picard Medical (PMI) has 3 years of Return on Sales data on file, last reported at 0.07% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 2.0% year-over-year to 0.07%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (up 8.0% YoY), and the FY2024 full-year result was 0.05%, changed N/A from the prior year.
• Return on Sales for Q1 2026 stood at 0.07%, down from 0.23% in the prior quarter.
• Across five years, Return on Sales topped out at 0.23% in Q4 2025 and bottomed at 0.11% in Q4 2024.
• The 3-year median for Return on Sales is 0.07% (2024), against an average of 0.04%.
• Peak annual rise in Return on Sales reached 33 bps in 2025, while the deepest fall reached 2 bps in 2025.
• A 3-year view of Return on Sales shows it stood at 0.11% in 2024, then jumped by 313 bps to 0.23% in 2025, then tumbled by 129 bps to 0.07% in 2026.
• The last three Return on Sales figures came in at 0.07% (Q1 2026), 0.23% (Q4 2025), and 0.09% (Q3 2025), per Business Quant data.

Peer Comparison